Design Therapeutics, Inc. - COM (DSGN)

Historical Portfolio Holders from Q1 2021 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
32.1M
Holdings value Q2 2024
$108M
Value change Q2 2024
+$4.41M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
92
Number of buys Q2 2024
8
Number of sells Q2 2024
-3
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 483K $2.6M +$188K $5.38 16
2024 Q2 32.1M $108M +$4.41M $3.35 92
2024 Q1 30.7M $124M -$3.11M $4.03 88
2023 Q4 31.7M $84M -$1.85M $2.65 87
2023 Q3 32.9M $77.6M -$67.8M $2.36 84
2023 Q2 38.8M $244M +$735K $6.30 96
2023 Q1 38.7M $223M -$16.1M $5.77 97
2022 Q4 40.4M $414M -$456K $10.26 82
2022 Q3 39.9M $667M +$24.3M $16.72 76
2022 Q2 38.7M $542M +$9.16M $14.00 70
2022 Q1 38M $614M +$27.8M $16.15 62
2021 Q4 36.2M $773M +$50.2M $21.41 58
2021 Q3 28.3M $415M +$5.82M $14.69 52
2021 Q2 27.8M $546M +$37.1M $19.89 49
2021 Q1 25.8M $755M +$755M $29.90 43